From SBA 7(a) loans to MSO structures and seller earnouts, here are the capital stack options that close deals in the $1M–$5M pain management market.
Acquiring a pain management clinic requires navigating both deal financing and healthcare-specific regulatory structures. Most lower middle market acquisitions combine an SBA 7(a) loan with seller financing, while non-physician buyers often layer in an MSO structure to comply with corporate practice of medicine laws. Understanding your capital stack options before approaching sellers gives you a significant negotiating advantage in this highly fragmented, compliance-intensive specialty.
The most common financing vehicle for pain clinic acquisitions under $5M. SBA 7(a) loans fund up to 90% of the purchase price, including goodwill, working capital, and equipment, making them ideal for established practices with clean DEA compliance histories.
Pros
Cons
Pain clinic sellers commonly carry 10–20% of the purchase price as a promissory note, often tied to physician transition support. This aligns seller incentives with buyer success and is frequently required by SBA lenders as a standby note.
Pros
Cons
Non-physician buyers use a Management Services Organization to acquire clinic assets and contract with a physician-owned Professional Corporation. PE-backed or search fund capital funds the MSO, with the physician PC retaining clinical control to satisfy corporate practice of medicine laws.
Pros
Cons
$2,500,000 (interventional pain clinic, $1.8M revenue, 28% EBITDA margin)
Purchase Price
~$21,500/month total debt service on SBA loan at 10.75% over 10 years
Monthly Service
~1.45x DSCR based on $504K EBITDA, comfortably above SBA minimum 1.25x threshold
DSCR
SBA 7(a) loan: $2,125,000 (85%) | Seller note on standby: $250,000 (10%) | Buyer equity/down payment: $125,000 (5%)
Yes, but only through an MSO structure in corporate practice of medicine states. A non-physician entity owns the management company; a licensed physician retains ownership of the clinical Professional Corporation. SBA lenders will finance the MSO side with proper legal documentation in place.
It depends on severity. Documented DEA audits, sanctions, or Medicare exclusions are serious red flags that can disqualify SBA financing. High-volume opioid prescribing without incidents may require additional compliance documentation but is not automatically disqualifying for most lenders.
Typically 90–120 days from signed LOI to close. Payer contract assignments, DEA registration transfers, and physician credentialing with insurers are the primary timeline drivers — start these processes immediately after LOI execution to avoid delays.
Most SBA lenders require a minimum 1.25x DSCR post-acquisition. For pain clinics, this typically corresponds to EBITDA margins of 20–28%+ depending on purchase price multiple. Margins below 18% often require additional equity injection or seller note subordination to qualify.
More Pain Management Clinic Guides
DealFlow OS surfaces acquisition targets and helps you structure the deal. Free to join.
Start finding deals — freeNo credit card required
For Buyers
For Sellers